Get the Stockscreener App
1.39
2.21%
0.03
After Hours:
1.30
-0.09
-6.47%
Tela Bio Inc stock is traded at $1.39, with a volume of 73,692.
It is up +2.21% in the last 24 hours and up +47.86% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$1.36
Open:
$1.34
24h Volume:
73,692
Relative Volume:
0.29
Market Cap:
$54.99M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-0.8323
EPS:
-1.67
Net Cash Flow:
$-44.47M
1W Performance:
-3.47%
1M Performance:
+47.86%
6M Performance:
-55.73%
1Y Performance:
-75.27%
1-Day Range:
$1.335
$1.41
1-Week Range:
$1.30
$1.53
52-Week Range:
$0.8645
$6.00
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.39 | 56.96M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
TELA Bio Approves Key Proposals at Annual Meeting - TipRanks
TELA Bio’s SWOT analysis: biologic innovator faces growth hurdles By Investing.com - Investing.com India
TELA Bio’s SWOT analysis: biologic innovator faces growth hurdles - Investing.com
TELA Bio to Present at the 2025 Jefferies Global Healthcare Conference - MSN
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference | TELA Stock News - GuruFocus
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference - GlobeNewswire
TELA Bio Brings Soft-Tissue Innovation Spotlight to Jefferies Healthcare Conference 2025 - Stock Titan
Investors Still Aren't Entirely Convinced By TELA Bio, Inc.'s (NASDAQ:TELA) Revenues Despite 39% Price Jump - simplywall.st
Piper Sandler maintains TELA Bio stock at Neutral with $2 target - Investing.com Australia
Cubist Systematic Strategies LLC Acquires 15,283 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio Reports Q1 2025 Growth and Product Expansion - MSN
TELA Bio Announces Inducement Grants to New Hires with 4-Year Vesting Plan - MSN
TELA Bio announces inducement grants - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5 - GuruFocus
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates - MSN
TELA Bio’s Earnings Call: Growth Amid Challenges - TipRanks
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TELA Stock News - GuruFocus
TELA Bio revenue up 12% to USD 18.5 million in Q1 2025 - Medical Buyer
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - Yahoo Finance
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Rev - GuruFocus
TELA Bio (NASDAQ:TELA) vs. Inspire Medical Systems (NYSE:INSP) Critical Contrast - The AM Reporter
TELA Bio Reports Strong Q1 2025 Revenue Growth - TipRanks
TELA Bio Reports First Quarter 2025 Financial Results - GlobeNewswire
Earnings call transcript: Tela Bio Q1 2025 revenue miss, stock rises 9% - Investing.com India
TELA Bio Reports Q1 2025 Revenue Growth Amid Losses - TipRanks
TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) & TELA Bio (NASDAQ:TELA) Critical Analysis - Defense World
TELA Bio Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Short Interest in TELA Bio, Inc. (NASDAQ:TELA) Drops By 14.6% - Defense World
Favourable Signals For TELA Bio: Numerous Insiders Acquired Stock - Yahoo Finance
JPMorgan Chase & Co. Increases Stock Holdings in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Geode Capital Management LLC Buys 136,890 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Renaissance Technologies LLC Has $1.28 Million Stake in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Critical Analysis: TELA Bio (NASDAQ:TELA) & Retractable Technologies (NYSE:RVP) - Defense World
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... - Yahoo
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with Strategic Initiatives - GuruFocus
TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN
TELA Bio to Announce First Quarter 2025 Financial Results | TELA Stock News - GuruFocus
TELA Bio to Announce First Quarter 2025 Financial Results - GlobeNewswire
TELA Bio, Inc. (NASDAQ:TELA) Stock Position Boosted by Commonwealth Equity Services LLC - Defense World
Prudential Financial Inc. Takes $57,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):